Literature DB >> 15311358

Successful treatment of steroid-refractory neurosarcoidosis with infliximab.

M Sollberger, F Fluri, T Baumann, S Sonnet, M Tamm, A J Steck, M Brutsche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15311358     DOI： 10.1007/s00415-004-0432-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  17 in total

1.  Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Authors:  Fleur Cohen Aubart; Diane Bouvry; Damien Galanaud; Caroline Dehais; Guillaume Mathey; Dimitri Psimaras; Julien Haroche; Corinne Pottier; Miguel Hie; Alexis Mathian; Hervé Devilliers; Hilario Nunes; Dominique Valeyre; Zahir Amoura
Journal:  J Neurol       Date:  2017-03-04       Impact factor: 4.849

2.  Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab.

Authors:  R C Chou; J W Henson; D Tian; E T Hedley-Whyte; A M Reginato
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

3.  Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab.

Authors:  Michael Marnane; Timothy Lynch; Jaqueline Scott; John Stack; Peter J Kelly
Journal:  J Neurol       Date:  2009-01-31       Impact factor: 4.849

4.  Infliximab in the treatment of rheumatoid meningoencephalitis.

Authors:  Felix Luessi; Janina Sollors; Harald Müller; Peter Stoeter; Clemens Sommer; Thomas Vogt; Frank Birklein; Frank Thömke
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

Review 5.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 6.  Inflammatory neuropathies: an update on evaluation and treatment.

Authors:  Lisa D Hobson-Webb; Peter D Donofrio
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

Review 7.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

8.  Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

Authors:  Michael Moravan; Benjamin M Segal
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

9.  Dramatic response to infliximab in refractory neurosarcoidosis.

Authors:  Sreekanth Chintamaneni; Aarat M Patel; Samuel B Pegram; Hirenkumar Patel; Heidi Roppelt
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

10.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.